This is a Study to Determine the Antidepressant Effects of AZD6765

NCT00986479 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment Resistant Major Depressive Disorder

Interventions

DRUG: AZD6765
DRUG: Placebo to AZD6765

Sponsor

AstraZeneca

Collaborators

[object Object]